MARSEILLE, France — A French microbiologist who became a controversial figure in the science world — and gained a popular cult following — for promoting dubious cures for covid-19 is set to be ...

A Red State’s High Court Gave Sam Alito the Dobbs Rejoinder He Deserves Sonia Sotomayor Just Vindicated the Rights of the Incarcerated to Seek Appeals President Donald Trump’s daily press briefing on ...

It lasted one year, from October 1993 to October 1994. The homeless people who showed at the emergency rooms of “Hôpitaux de Marseille” were treated by local medical teams. Of these, 43 were admitted ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 study ...

The study by Didier Raoult et. al., the one partly responsible for the massive, unwarranted use of hydroxychloroquine for COVID, has been picked to bits by a review panel hired by the journal that ...

The medication hydroxychloroquine was touted by right-wing media figures and others as an effective treatment for covid-19. Research later showed it was not and could even pose harmful side effects ...

Mutant strains of COVID-19 that are more contagious, but less serious, have turned up in France, possibly explaining why Europe is reporting a spike in confirmed cases. The chief of a leading French ...

On 24 March, Professor Didier Raoult slammed the door on the circle of researchers who were supposed to advise the French president on the pandemic. Disagreeing with the containment policy adopted by ...

Illustration picture shows a pharmacist holding a box of Plaquenil, Monday 06 April 2020. Belgium goes into its fourth week of confinement in the ongoing corona virus crisis. There are lots of debate ...

A French doctor who popularized the now-discredited hydroxychloroquine treatment for COVID-19 is under fire for an alleged pattern of unauthorized experiments on homeless people. Didier Raoult, a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Last week, ...